Searchable abstracts of presentations at key conferences in endocrinology

ea0081rc12.5 | Rapid Communications 12: Reproductive and Developmental Endocrinology | ECE2022

Association of Early Adulthood Hyperandrogenemia With Hypertension and Cardiovascular Events in Women

Tuorila Katri , Ollila Meri-Maija , Jarvelin Marjo-Riitta , Tapanainen Juha , Franks Stephen , Piltonen Terhi , Kaikkonen Kari , Morin-Papunen Laure

Background: Cardiovascular diseases (CVD) present sex specific characteristics, suggesting sex-hormones playing a role in the pathophysiology of CVDs. Hyperandrogenemia (HA) is a common condition in fertile age women but whether HA is a risk factor for CVD is still controversial.Aims: To clarify the association of HA with the development of hypertension and CVDs in women.Study population and methods: A general population-based birt...

ea0049ep1110 | Female Reproduction | ECE2017

Hyperandrogenism and overweight/obesity, independently and interactively, increase the risk of metabolic syndrome and type 2 diabetes in women – a Prospective, Population-based Cohort Study

Ollila Meri-Maija , Kaikkonen Kari , Keinanen-Kiukaanniemi Sirkka , Puukka Katri , Ruokonen Aimo , Jarvelin Marjo-Riitta , Tapanainen Juha , Franks Steve , Piltonen Terhi , Morin-Papunen Laure

The significance of hyperandrogenism (HA) as a metabolic risk factor in women is controversial. HA can be defined as either clinical (hirsutism) or biochemical (elevated androgen levels). We aimed to investigate whether HA at age 31 associates with metabolic syndrome (MetS), type 2 diabetes mellitus (DM2) or carotid intima media thickness (CIMT) by age 46. In a prospective, general population-based follow-up birth cohort (n=5889 women) blood samples were collected at ...